Financial & competing interests disclosure
DA Spiegel has served as a consultant for Novartis Institute for Biomedical Research, and the Spiegel laboratory has received research funding from Novartis Institute for Biomedical Research and Bristol–Myers Squibb. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.